BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15695296)

  • 41. Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers.
    Seong SS; Choi CB; Woo JH; Bae KW; Joung CL; Uhm WS; Kim TH; Jun JB; Yoo DH; Lee JT; Bae SC
    J Rheumatol; 2007 Apr; 34(4):706-11. PubMed ID: 17309133
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis.
    de Vries MK; van der Horst-Bruinsma IE; Nurmohamed MT; Aarden LA; Stapel SO; Peters MJ; van Denderen JC; Dijkmans BA; Wolbink GJ
    Ann Rheum Dis; 2009 Apr; 68(4):531-5. PubMed ID: 18375542
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis.
    Miceli-Richard C; Comets E; Verstuyft C; Tamouza R; Loiseau P; Ravaud P; Kupper H; Becquemont L; Charron D; Mariette X
    Ann Rheum Dis; 2008 Apr; 67(4):478-84. PubMed ID: 17673491
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lymphotoxin-α 252 A>G polymorphism: a link between disease susceptibility and dyslipidemia in rheumatoid arthritis?
    Santos MJ; Fernandes D; Caetano-Lopes J; Perpetuo IP; Vidal B; Canhao H; Fonseca JE
    J Rheumatol; 2011 Jul; 38(7):1244-9. PubMed ID: 21459939
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacogenetics and future therapeutic scenarios: what affects the prediction of response to treatment with etanercept?
    Murdaca G; Gulli R; Spanò F; Mandich P; Puppo F
    Drug Dev Res; 2014 Nov; 75 Suppl 1():S7-S10. PubMed ID: 25381983
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patients non-responding to etanercept obtain lower etanercept concentrations compared with responding patients.
    Jamnitski A; Krieckaert CL; Nurmohamed MT; Hart MH; Dijkmans BA; Aarden L; Voskuyl AE; Wolbink GJ
    Ann Rheum Dis; 2012 Jan; 71(1):88-91. PubMed ID: 21914626
    [TBL] [Abstract][Full Text] [Related]  

  • 48. -174G/C interleukin-6 gene promoter polymorphism predicts therapeutic response to etanercept in rheumatoid arthritis.
    Jančić I; Arsenović-Ranin N; Sefik-Bukilica M; Zivojinović S; Damjanov N; Spasovski V; Srzentić S; Stanković B; Pavlović S
    Rheumatol Int; 2013 Jun; 33(6):1481-6. PubMed ID: 23233117
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab.
    Ruyssen-Witrand A; Rouanet S; Combe B; Dougados M; Le Loët X; Sibilia J; Tebib J; Mariette X; Constantin A
    Ann Rheum Dis; 2012 Jun; 71(6):875-7. PubMed ID: 22368231
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association between -871C>T promoter polymorphism in the B-cell activating factor gene and the response to rituximab in rheumatoid arthritis patients.
    Ruyssen-Witrand A; Rouanet S; Combe B; Dougados M; Le Loët X; Sibilia J; Tebib J; Mariette X; Constantin A
    Rheumatology (Oxford); 2013 Apr; 52(4):636-41. PubMed ID: 23264555
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigation of single nucleotide polymorphisms and biological pathways associated with response to TNFα inhibitors in patients with rheumatoid arthritis.
    Krintel SB; Palermo G; Johansen JS; Germer S; Essioux L; Benayed R; Badi L; Ostergaard M; Hetland ML
    Pharmacogenet Genomics; 2012 Aug; 22(8):577-89. PubMed ID: 22569225
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Allele-specific binding of the ubiquitous transcription factor OCT-1 to the functional single nucleotide polymorphism (SNP) sites in the tumor necrosis factor-alpha gene (TNFA) promoter.
    Hohjoh H; Tokunaga K
    Genes Immun; 2001 Apr; 2(2):105-9. PubMed ID: 11393654
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of anti-CCP positivity and carriage of TNFRII susceptibility variant with anti-TNF-α response in rheumatoid arthritis.
    Vasilopoulos Y; Bagiatis V; Stamatopoulou D; Zisopoulos D; Alexiou I; Sarafidou T; Settas L; Sakkas L; Mamouris Z
    Clin Exp Rheumatol; 2011; 29(4):701-4. PubMed ID: 21813066
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TNF-alpha gene polymorphisms can help to predict response to etanercept in psoriatic patients.
    De Simone C; Farina M; Maiorino A; Fanali C; Perino F; Flamini A; Caldarola G; Sgambato A
    J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1786-90. PubMed ID: 25726968
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic variability in the severity and outcome of community-acquired pneumonia.
    Solé-Violán J; de Castro Fv; García-Laorden MI; Blanquer J; Aspa J; Borderías L; Briones ML; Rajas O; Carrondo IM; Marcos-Ramos JA; Ferrer Agüero JM; Garcia-Saavedra A; Fiuza MD; Caballero-Hidalgo A; Rodriguez-Gallego C
    Respir Med; 2010 Mar; 104(3):440-7. PubMed ID: 19900796
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Association of TNF-alpha polymorphism (-308 A/G) with high activity of rheumatoid arthritis and therapy response to Etanercept].
    Stojanović S; Jevtović-Stoimenov T; Stanković A; Pavlović D; Neković J; Stamenković B; Dimić A; Marinković M
    Srp Arh Celok Lek; 2011; 139(11-12):784-9. PubMed ID: 22338476
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic risk factors for infection in patients with early rheumatoid arthritis.
    Hughes LB; Criswell LA; Beasley TM; Edberg JC; Kimberly RP; Moreland LW; Seldin MF; Bridges SL
    Genes Immun; 2004 Dec; 5(8):641-7. PubMed ID: 15526004
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor necrosis factor-alpha -1031 T/C polymorphism is associated with smaller and more proatherogenic low density lipoprotein particles in patients with rheumatoid arthritis.
    Vallvé JC; Paredes S; Girona J; Uliaque K; Ribalta J; Hurt-Camejo E; Masana L
    J Rheumatol; 2008 Sep; 35(9):1697-703. PubMed ID: 18634161
    [TBL] [Abstract][Full Text] [Related]  

  • 59. No association between tumour necrosis factor receptor type 2 gene polymorphism and rheumatoid arthritis severity: a comparison of the extremes of phenotypes.
    van der Helm-van Mil AH; Dieudé P; Schonkeren JJ; Cornélis F; Huizinga TW
    Rheumatology (Oxford); 2004 Oct; 43(10):1232-4. PubMed ID: 15252214
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of associations between polymorphisms within genes coding for tumour necrosis factor (TNF)-alpha and TNF receptors and responsiveness to TNF-alpha blockers in patients with rheumatoid arthritis.
    Swierkot J; Bogunia-Kubik K; Nowak B; Bialowas K; Korman L; Gebura K; Kolossa K; Jeka S; Wiland P
    Joint Bone Spine; 2015 Mar; 82(2):94-9. PubMed ID: 25311255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.